Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

Pfizer reveals migraine treatment

June 7, 1996

Controlled-release oxycodone HCl now on U.S. shelves

June 7, 1996

More tachykinin antagonists described by Merck & Co.

June 7, 1996

Clinical trials on Diatide's Sn-117m DTPA

June 7, 1996

Tachykinin NK1 antagonists described by Ciba-Geigy

June 7, 1996

Production of recombinant human basic fibroblast growth factor covered by U.S. patent

May 31, 1996

Neurotrophic polypeptides disclosed by Children's Medical Center

May 31, 1996

Gedeon Richter discloses antiamnestic ethers

May 31, 1996

Pentynoic acid derivatives revealed by ABS and the University College Dublin

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...